France· FR:60368099
ONCOVIN 1 mg, solution injectable
A vincristine product containing sulfate de vincristine, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Vincristine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01CA02 (vincristine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Vincristine · ATC L01CA02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE VINCRISTINE
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- L01CA02
- ATC class
- Vincristine
- Defined daily dose
- 0.36 mg, P
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009326499831 flacon(s) en verre de 1 mlEUR 11.38
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
583 interactions on record for vincristine.
Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vincristine · interactions on record
583 records
- 63 severe
- 282 moderate
- 25 minor
- 213 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vincristine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomOncovin 1mg/1ml solution for injection vialsEli Lilly and Company Ltd
- SwitzerlandVincristin Teva 1 mg/1 ml, InjektionslösungTeva Pharma AG
- FinlandOncovinSTADA Nordic ApS
- CzechiaVINCRISTINE TEVATeva Pharmaceuticals CR, s.r.o., Praha
- GermanyCellcristinStadapharm Gmbh
- NetherlandsVincristinesulfaat Eureco-Pharma 1 mg/ml, oplossing voor injectieEureco-Pharma B.V.
- United StatesVinCRIStine SulfateHospira, Inc.
- CanadaVINCRISTINE SULFATE INJECTIONTEVA CANADA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Oncovin, Vincristin Pfizer
- Belgium · Vincrisin
- Czechia · Vincristine Teva
- Germany · Cellcristin, Vincristinsulfat Teva
- Denmark · Oncovin
- Spain · Vincristina Pfizer
- Finland · Oncovin
- United Kingdom (Northern Ireland) · Vincristine Sulfate Hospira Uk, Vincristine Sulfate Teva Uk
- Ireland · Vincristine Sulfate Pfizer Healthcare Ireland
- Italy · Vincristina, Vincristina Pfizer Italia
- Lithuania · Vincristine Teva
- Luxembourg · Vincrisin
- Latvia · Vincristine Teva
- Netherlands · Vincristinesulfaat Teva
- Norway · Vincristine Pfizer
- Poland · Vincristine Teva
- Portugal · Vincristina Teva
- Romania · Sindovin, Vincristină Teva
- Sweden · Oncovin, Vincristine Pfizer
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/36ecd474-52b7-4bfe-a2ac-ab4ff42e0a46 GET /v1/drugs/36ecd474-52b7-4bfe-a2ac-ab4ff42e0a46?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60368099",
"date_amm": "1997-12-23",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE DE VINCRISTINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about vincristine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.